Comparison Between the Assessment of Anxious and Depressive Symptomology
EDAPAL
1 other identifier
observational
100
1 country
1
Brief Summary
In palliative care, anxiety and depression in advanced cancer are under evaluated, under diagnosed and therefore under treated. 5 to 30% of patients present anxious and depressive disorders. Physical symptoms are easy to assess. But in palliative care it is important to take care of moral suffering. However, evaluation and management of patient's anxiety and depressive symptoms are difficult for physicians and caregivers. The investigators would like to specifically compare the patient's evaluation of anxious and depressive symptomatology in palliative care with the evaluation by the physician, the nurse and the caregiver. Then the investigators will try to collect the caregivers's difficulties in the management of anxious and depressive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedStudy Start
First participant enrolled
November 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 13, 2020
CompletedJuly 27, 2021
July 1, 2021
12 months
October 31, 2019
July 26, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of the anxious and depressive symptomatology of hospitalized patients in palliative care unit (USP) evaluated on the one hand by the patient himself and on the other hand, in hetero evaluation, by caregivers.
The Edmonton Symptom Assessment Scale (ESAS) will be used for assess anxiety and depression intensity. The ESAS is a self-reported outcome tool assessing the intensity of nine symptoms (pain, tiredness, nausea, depressive mood, anxiety, drowsiness, lack of appetite, wellbeing, and breathlessness). Intensity is rated using 10-point Likert-scales from "no-symptom" (scored 0) to "worst possible symptom" (scored 10) The difference of evaluation for anxiety and depressive symptoms is considere significant when there are two points and more between ESAS patient's and ESAS caregivers'.
72 hours
Study Arms (4)
Patients
Anyone who is hospitalized in the palliative care service of the Lyon Sud Hospital Center.
Doctors
Doctors taking care of patients in the study will be solicited by the research nurse or a study investigator.
Nurses
Nurses taking care of patients in the study will be solicited by the research nurse or a study investigator.
Caregivers
Caregivers taking care of patients in the study will be solicited by the research nurse or a study investigator.
Interventions
Patients complete a questionnaire for assess their symptoms like anxiety and depression. These questionnaires contains: * socio-demographic characteristics : sex, age, type and stage of cancer, performans status * ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms * HADS - A : Hospital Anxiety and Depression scale includes 2 subscales which assess anxiety (HADS-A) and depression (HADS-D) * BEDS : Brief Edimburg depression Scale is s a relevant scale for assess depression in palliative care patients. * Questions on the assessment, the treatment and difficulties in management of anxious and depressive symptoms. The evaluation will be realized in the first days of hospitalization (72 hours).
Questionnaire is different from caregivers. The evaluation will be realized in the first days of hospitalization (72 hours). Physicians, nurses and caregivers complete another questionnaire. The physician questioned will be the doctor of unit having received the patient, or the doctor of the mobile team of palliative care having admitted the patient in the unit. These questionnaires contains: * socio-demographic characteristics : sex, age, type and stage of cancer, performans status * ESAS : Edmonton Symptom Assessement Scale is a validated tool for assessment of several symptoms
Eligibility Criteria
All patients hospitalized in our palliative care unit
You may qualify if:
- Patients :
- Adult patients (18 years and over)
- Advanced cancer stage
- Patients hospitalized less than 72 hours in Lyon Sud palliative care unit
- Sufficient general conditions to complete survey
- Absence of cognitive disorders
- Agreement to participate at the study
- Medical Staff:
- \- Working full time or part time in the USP or the PMSC of CHLS
You may not qualify if:
- Patients :
- Minor patients
- Patients hospitalized more than 72 hours in Lyon Sud palliative care unit
- Presence of cognitive disorders
- Alteration of general conditions
- Refusal to participate at the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Lyon Sud
Pierre-Bénite, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Audrey FAWOUBO, MD
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2019
First Posted
November 4, 2019
Study Start
November 15, 2019
Primary Completion
November 13, 2020
Study Completion
November 13, 2020
Last Updated
July 27, 2021
Record last verified: 2021-07